Literature DB >> 23543987

Myeloperoxidase: a new twist to an old tale.

Usha Anand1, C V Anand.   

Abstract

Entities:  

Year:  2012        PMID： 23543987      PMCID： PMC3358362          DOI： 10.1007/s12291-012-0220-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


× No keyword cloud information.
  24 in total

1.  Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids.

Authors:  C Jolivalt; B Leininger-Muller; P Bertrand; R Herber; Y Christen; G Siest
Journal:  Free Radic Biol Med       Date:  2000-01-01       Impact factor: 7.376

2.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; S L North; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

3.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Authors:  S L Hazen; J W Heinecke
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates.

Authors:  W A Prütz
Journal:  Arch Biochem Biophys       Date:  1996-08-01       Impact factor: 4.013

Review 5.  Myeloperoxidase.

Authors:  S J Klebanoff
Journal:  Proc Assoc Am Physicians       Date:  1999 Sep-Oct

6.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production.

Authors:  Astrid Haegens; Peter Heeringa; Robert Jan van Suylen; Chad Steele; Yasuaki Aratani; Robert J J O'Donoghue; Steven E Mutsaers; Brooke T Mossman; Emiel F M Wouters; Juanita H J Vernooy
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.

Authors:  Ada Stefanescu; Siegmund Braun; Gjin Ndrepepa; Tobias Koppara; Herribert Pavaci; Julinda Mehilli; Albert Schömig; Adnan Kastrati
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

9.  Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids.

Authors:  Adam Barczyk; Ewa Sozañska; Marzena Trzaska; Wladyslaw Pierzchala
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

10.  In vivo damage of rat lungs by oxygen metabolites.

Authors:  K J Johnson; J C Fantone; J Kaplan; P A Ward
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808
View more
  2 in total

1.  Myeloperoxidase G463A polymorphism and risk of lung cancer.

Authors:  Junrui Li; Yingju Fu; Baochun Zhao; Ying Xiao; Ruiying Chen
Journal:  Tumour Biol       Date:  2013-08-25

2.  CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients.

Authors:  Lourdes Barrera; Edgar Montes-Servín; Juan-Manuel Hernandez-Martinez; María de Los Ángeles García-Vicente; Elizabeth Montes-Servín; Marytere Herrera-Martínez; José C Crispín; José Rafael Borbolla-Escoboza; Oscar Arrieta
Journal:  Br J Cancer       Date:  2017-06-20       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.